EXELIXIS, INC. EXEL 55.45
Health Care · NASDAQ · Data as of 2026-08-05
EXELIXIS, INC. (EXEL) has delivered +26.8% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #696 of 1983 stocks overall and #66 of 263 in the Health Care sector by Steady Score.
Industry
Biological Products
Steady Score
55.45
Overall Rank
#696 / 1983
Sector Rank
#66 / 263
Revenue CAGR
+26.8%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio